Following the recognition of the National Drug Authority as a Uganda Drug Policy Actualisation Champion by Public Opinions with the Responsible Investment Global Award 2026, news has spread rapidly across the country. People from all walks of life, particularly leaders within the National Resistance Movement, have praised the authority for its outstanding efforts to protect and advance health sector gains.
The National Drug Authority, led by the distinguished public servant and medical expert Dr. David Nahamya, was officially honoured in October 2026 with the prestigious Responsible Investment Global Award. In addition to this national recognition, the authority was inducted onto the Uganda Best 12 Public Institutions Hall of Fame poster for its operational excellence.
To celebrate these achievements, Public Opinions will distribute 500,000 commemorative posters nationwide through national NRM structures, district leadership networks, and retail outlets. This mass dissemination campaign aims to highlight the remarkable contributions of top-performing public bodies that actively drive national development and fulfill government priorities.
Securing a prominent position among the top twelve public institutions in Uganda reflects an organization operating at the highest level of regulatory efficiency. The award serves as a clear testament to the institution’s unwavering commitment to public health, administrative integrity, and transparent governance across the pharmaceutical sub-sector.
Dr. David Nahamya, Secretary to the Authority, has received widespread praise from Ugandans, especially youth and women, for promoting exceptional professionalism in his execution of duty. His strategic leadership and clinical expertise have been instrumental in protecting citizens from the dangerous proliferation of counterfeit and substandard medical products.
Buyinza Adam Luzindana, CEO of Public Opinions, emphasized that the fundamental mandate of the National Drug Authority is to guarantee the continuous availability of safe, efficacious, and cost-effective human and veterinary medicines nationwide. This statutory purpose remains central to every regulatory policy and enforcement strategy implemented by the executive leadership.
To fulfill this vital mandate, the authority strictly regulates pharmacies, drug outlets, and pharmaceutical services while approving essential revisions to the national drug list. It continuously estimates national pharmaceutical requirements to ensure reliable,uninterrupted sourcing for both public health facilities and private commercial distributors.
The authority maintains rigid control over the importation, exportation, distribution, and sale of all pharmaceuticals across Uganda. Through systematic market surveillance, routine quality monitoring, and rigorous laboratory testing, it protects public health by quickly identifying and eliminating unsafe, contaminated, or falsified medical supplies from circulation.
Beyond basic regulation, the authority actively promotes domestic pharmaceutical manufacturing and encourages scientific research into indigenous herbal remedies. It fosters rational drug use across urban and rural communities through comprehensive training programs, professional guidelines, and targeted public health safety communications.
Furthermore, the authority provides expert technical advice to the Minister of Health on critical pharmaceutical policies and legislative reforms. It enforces regulatory compliance by licensing qualified drug outlets, conducting unannounced facility inspections, and executing product recalls or legal penalties against offenders.
Through these consistent regulatory achievements, the National Drug Authority joins an elite group of top-performing public institutions recognized by Public Opinions. This distinguished group includes the Electricity Regulatory Authority, State House, the UPDF, the Ministry of Health, the Ministry of Defence, the Judiciary of Uganda, and Operation Wealth Creation.
The NRM Manifesto 2026–2031, themed “Protecting the Gains,” prioritizes the continuous improvement of Uganda’s health sector and the safeguarding of public pharmaceutical supplies. A central policy commitment focuses on strengthening the authority’s structural capacity to detect and eliminate counterfeit medicines, vaccines, medical equipment, and dietary supplements.
Under the visionary leadership of President Yoweri Kaguta Museveni, the Government of Uganda firmly recognizes access to quality healthcare as a fundamental human right. The authority’s strategic vision directly aligns with this presidential directive by ensuring equitable access to safe medicines across both public and private healthcare settings.
Guided by its vision to be a globally recognized regulatory authority and its mission to safeguard public health, the NDA has successfully translated its strategic objectives into tangible national outcomes. Its comprehensive operational framework connects directly to key National Development Plan IV programs to foster sustained socioeconomic growth.
These strategic linkages span critical national program areas, including Human Capital Development, Manufacturing, Sustainable Energy, Agro-Industrialization, and Private Sector Development. By regulating agro-based pharmaceutical raw materials of plant and animal origin, the authority enhances agricultural value addition while expanding domestic market competitiveness.
To ensure global best practices, the authority’s National Drug Quality Control Laboratory has successfully retained its WHO prequalification status. Furthermore, the institution maintains ISO 9001:2015 certification for its Quality Management System, guaranteeing international standards across all laboratory testing, inspection, and administrative processes.
The authority has also strengthened systems for Adverse Drug Reaction reporting across human and veterinary health, documenting over 20,000 comprehensive reports. Premarket authorization processes have successfully evaluated thousands of product applications, effectively driving up the overall quality rate of market pharmaceuticals to 94 percent.
Operating under firm core values of integrity, collaboration, accountability, responsibility, and excellence, the authority has secured ISO 17025 accreditation for medicines and medical devices. It has also been designated a Center of Excellence for Good Manufacturing Practice by NEPAD, boosting public and international trust.
Under Dr. Nahamya’s leadership, the authority has accelerated digital transformation by migrating core regulatory workflows from NDAMIS to the advanced iRIMS platform. This technological modernization streamlines online applications for premises licensing, import-export verification, drug registration, and real-time performance tracking through interactive dashboards.
Public Opinions deserves immense credit for its persistent work in evaluating, identifying, and rewarding high-performing public leaders and state institutions. By honoring entities like the NDA, Public Opinions creates essential public awareness around President Museveni’s transformative achievements and secures lasting health gains for all Ugandans.Public Opinions is available at www.publicopinions.net and whatsapp:+256774992426
